- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03661918
CHAT at HOME Pilot Study
September 23, 2019 updated by: University of Minnesota
Changing Habits Together at Home Pilot Study
This study is evaluating the acceptability and feasibility of a 10 session parent-targeted phone-based childhood obesity treatment (n=40).
A factorial design (2 X 2 X 2) will be used to examine the acceptability and feasibility of 3 intervention components: 1) the first session being conducted in person, 2) involving a second adult caregiver, and 3) a weekly weighing of child via WiFi-enabled scales.
Study Overview
Status
Completed
Conditions
Detailed Description
All participants in this study will receive 10 core coaching sessions.
These sessions will be conducted between study staff and parents of children ages 8 - 12 who are in the 85th percentile or higher on the BMI scale.
The sessions will focus on healthy habits and positive reinforcement for behavior changes within the house that could lead to a reduction in the the child's BMI.
In addition to the 10 core sessions, some participants will have difference components of the intervention added to their treatment: conducting the first session in-person, having a second caregiver participate in some of the coaching calls, and/or having the child use a wifi-enabled scale for weekly weigh-ins.
Study Type
Interventional
Enrollment (Actual)
32
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Minnesota
-
Minneapolis, Minnesota, United States, 55454
- University of Minnesota
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
8 years and older (Child, Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Parent/primary caregiver of child in the 8-12 year old age range based on child birth date
- The child's BMI is greater than or equal to the 85th percentile according to CDC age and sex reference standards
- Child lives with parent/primary caregiver 50% of the time
- Willing to have a second caregiver participate in this study
- Wifi at home
- The parent and child can speak, read, and understand English
Exclusion Criteria:
- Kidney disease, Type 1 diabetes, Lupus, current Cancer diagnosis,
- Chromosomal abnormality such as Down's syndrome or Turner's syndrome
- Child taken any steroid medications such as Prednisone, Prenisilone and Decadron on a daily basis for more than 1 month in the past 6 months (this does not include inhalers with steroids)
- Child enrolled in a different weight management program
- Family participating in any other child research study related to dietary intake, physical activity, weight
- Plans to move more than 50 miles from your present location within the next 6 months
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Group 1
In-person first session, no second caregiver, no wifi-enabled scale
|
Conduct first session in person vs. over the phone
|
Other: Group 2
In-person first session, no second caregiver, wifi-enabled scale
|
Conduct first session in person vs. over the phone
Have participant weigh in weekly on a wifi-enabled scaled vs. regular scale
|
Other: Group 3
In-person first session, second caregiver, no wifi-enabled scale
|
Conduct first session in person vs. over the phone
Have second caregiver participate in three coaching calls
|
Other: Group 4
In-person first session, second caregiver, wifi-enabled scale
|
Conduct first session in person vs. over the phone
Have participant weigh in weekly on a wifi-enabled scaled vs. regular scale
Have second caregiver participate in three coaching calls
|
Other: Group 5
No in-person first session, no second caregiver, no wifi-enabled scale.
10 core coaching calls only
|
Participant will receive 10 core phone coaching sessions
|
Other: Group 6
No in-person first session, no second caregiver, wifi-enabled scale
|
Have participant weigh in weekly on a wifi-enabled scaled vs. regular scale
|
Other: Group 7
No in-person first session, second caregiver, no wifi-enabled scale
|
Have second caregiver participate in three coaching calls
|
Other: Group 8
No in-person first session, second caregiver, wifi-enabled scale
|
Have participant weigh in weekly on a wifi-enabled scaled vs. regular scale
Have second caregiver participate in three coaching calls
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Feasibility Data
Time Frame: 4 months
|
Demonstrate feasibility and acceptability of the intervention components as measured by high participation rates in and satisfaction with all experimental arms.
|
4 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Child BMI
Time Frame: 4 months
|
Track and measure child BMI percentiles at beginning and end of study.
|
4 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Nancy Sherwood, PhD, University of Minnesota
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 27, 2018
Primary Completion (Actual)
September 1, 2019
Study Completion (Actual)
September 1, 2019
Study Registration Dates
First Submitted
September 5, 2018
First Submitted That Met QC Criteria
September 5, 2018
First Posted (Actual)
September 7, 2018
Study Record Updates
Last Update Posted (Actual)
September 25, 2019
Last Update Submitted That Met QC Criteria
September 23, 2019
Last Verified
September 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- STUDY00004193
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Childhood Obesity
-
Universiteit LeidenWageningen University; Nutricia, Inc.; Danone ResearchCompletedChildhood Obesity | Childhood Overweight | Vegetable Acceptance in Early ChildhoodNetherlands
-
Vanderbilt University Medical CenterActive, not recruitingPediatric Obesity | Childhood Obesity | Childhood Onset ObesityUnited States
-
Tehran University of Medical SciencesUnknownChildhood Obesity PreventionIran, Islamic Republic of
-
Oregon State UniversityCompletedChildhood Obesity Prevention
-
The Miriam HospitalHassenfeld Child Health Innovation InstituteCompletedChildhood Obesity PreventionUnited States
-
Fundacion para la Formacion e Investigacion Sanitarias...UnknownChildhood Obesity PreventionSpain
-
Tampere UniversitySeinajoki Central Hospital; Tampere University Hospital; Foundation for Paediatric... and other collaboratorsCompleted
-
Harokopio UniversityCompletedPrevention of Childhood ObesityGreece
-
Cornell UniversityCompletedChildhood Obesity Prevention
-
University of Alabama at BirminghamCompletedObesity, Childhood | Overweight, ChildhoodUnited States
Clinical Trials on In-Person First Session
-
Herlev and Gentofte HospitalUniversity of CopenhagenCompletedMalignant Melanoma | Cancer of Cervix | Cancer of the Prostate | Cancer, Ovarian | Lymphedema of Leg | Cancer, EndometrialDenmark
-
University of California, San FranciscoNational Institute on Alcohol Abuse and Alcoholism (NIAAA); Syracuse University and other collaboratorsCompletedHIV/AIDS | Alcohol Use, UnspecifiedUganda
-
Dartmouth-Hitchcock Medical CenterCompletedPrimary Malignant Neoplasm of Lung | Primary Malignant Neoplasm of Gastrointestinal TractUnited States
-
Mari PakkonenCompletedNurse-Patient RelationsFinland
-
University of ConnecticutNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)RecruitingAnterior Cruciate Ligament ReconstructionUnited States
-
Mayo ClinicCompletedTelemedicine | Primary Health Care | Diagnosis | Therapeutics | Developing CountriesHonduras
-
University of VermontNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University...Completed
-
Linnaeus UniversityRecruiting
-
Norges idrettshøgskoleKristiania University College; ABEL TechnologiesRecruiting